Multiple system atrophy trials in Austria

2 of 4 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 1Taking people
  Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adults With Multiple System Atrophy (HORIZON)

  Where

  Innsbruck

  Age

  40 years to 70 years

  People

  40 worldwide

  Run by

  Ionis Pharmaceuticals, Inc.

  See details and how to joinNCT04165486 · EU 2024-512528-13-00
• No phaseTaking people
  Medical Decision Making in Multiple System Atrophy

  Where

  Innsbruck

  Age

  30 years and over

  People

  92

  Run by

  Medical University Innsbruck

  See details and how to joinNCT06072105